Integer  Corporation logo

Integer Corporation

ITGR | NYSE
Chart Builder DCF Calculator
$126.38
+$0.10 (+0.08%)
At close: Sep 21, 2026, 4:00 PM ET
$126.38
$0 (0.00%)
After-hours: Sep 21, 2026, 5:59 PM ET

Company Profile

Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.

Key Executives

Name Position
Payman Khales Chief Executive Officer, President & Director
Carol Russell Vice President & Chief Information Officer
Diron Smith Executive Vice President & Chief Financial Officer
Andrew Senn President of Growth & Innovation
Jim Stephens Executive Vice President of Special Projects
John Harris President of Global Operations & Manufacturing Technology
Kirk K. Thor Executive Vice President & Chief Human Resources Officer
Kristen Marie Stewart Director of Investor Relations
Lindsay Krause Blackwood Senior Vice President, General Counsel, Chief Ethics & Compliance Officer and Corporate Secretary
Sanjiv Arora Senior Vice President of Strategy, Business Development and Investor Relations
Tom Thomas Vice President, Corporate Controller & Principal Accounting Officer
Tony Carr Executive Vice President of Global Quality & Regulatory Affairs

Latest SEC Filings

Date Type Title
Sep 03, 2026 PREM14A Filing
Aug 19, 2026 DEFA14A Filing
Aug 14, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Aug 04, 2026 10-Q Quarterly Report
Aug 04, 2026 DEFA14A Filing
Aug 04, 2026 8-K Current Report
Aug 03, 2026 DEFA14A Filing
Aug 03, 2026 DEFA14A Filing
Aug 03, 2026 DEFA14A Filing
Aug 03, 2026 DEFA14A Filing
View All SEC Filings
Integer Corporation
Integer  Corporation logo
Country United States
IPO Date Sep 28, 2000
Industry Medical - Devices
Sector Healthcare
Employees 11,000
CEO Payman Khales

Contact Details

5830 Granite Parkway Plano, Texas 75024 United States

Stock Details

Ticker Symbol ITGR
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001114483
CUSIP Number 45826H109
ISIN Number US45826H1095
SIC Code 3690

© 2026 bestshares.com. All rights reserved.